✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vista Pharmaceuticals Ltd.

VISTAPH

Market Cap
₹43 Cr.
P/E
0.00

Vista Pharmaceuticals Ltd.

  • Vista Pharma
  • Goldline Pharma.
  • Rajnish Wellness

FAQs on Vista Pharmaceuticals Ltd. Shareprice

Vista Pharmaceutical has given better returns compared to its competitors.
Vista Pharmaceutical has grown at ~-27.04% over the last 2yrs while peers have grown at a median rate of -46.0%

There is insufficient historical data to gauge this.
Latest PE of Vista Pharmaceutical is 0

View FAQ's On Business

Growth Table

  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Balance Sheet

  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Cash Flow

  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Quarterly Results

  • Vista Pharmaceuticals Ltd.
  • Goldline Pharma.
  • Rajnish Wellness

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vista Pharmaceuticals Ltd. Financials

Vista Pharmaceutical balance sheet is weak and might have solvency issues

Yes, The net debt of Vista Pharmaceutical is increasing.
Latest net debt of Vista Pharmaceutical is ₹9.88 Crs as of Mar-26.
This is greater than Mar-25 when it was ₹5.95 Crs.

No, profit is decreasing.
The profit of Vista Pharmaceutical is -₹12.06 Crs for TTM, -₹4.65 Crs for Mar 2025 and -₹4.51 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vista Pharmaceutical latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech